A blueprint for better cancer immunotherapies
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
Marzyeh Ghassemi works to ensure health-care models are trained to be robust and fair.
Thomas Heldt, associate director of IMES, describes how he collaborates closely with MIT colleagues and others at Boston-area hospitals.
“MouthIO” is an in-mouth device that users can digitally design and 3D print with integrated sensors and actuators to capture health data and interact with a computer or phone.
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
While women and men self-reported similar vaccination rates, unvaccinated women had less intention to get vaccinated than men.
A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.
The minimally invasive, 3d-printable device offers safer application and removal, along with improved bioelectronic performance.
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
Three innovations by an MIT-based team enable high-resolution, high-throughput imaging of human brain tissue at a full range of scales, and mapping connectivity of neurons at single-cell resolution.
Co-hosted by the McGovern Institute, MIT Open Learning, and others, the symposium stressed emerging technologies in advancing understanding of mental health and neurological conditions.